Slate Path Capital as of Dec. 31, 2016
Portfolio Holdings for Slate Path Capital
Slate Path Capital holds 15 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 30.6 | $1.0B | 4.5M | 223.53 | |
| Financial Select Sector SPDR (XLF) | 19.2 | $630M | 27M | 23.25 | |
| Technology SPDR (XLK) | 6.6 | $218M | 4.5M | 48.36 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 6.6 | $216M | 750k | 287.92 | |
| Ally Financial (ALLY) | 6.0 | $198M | 10M | 19.02 | |
| General Motors Company (GM) | 6.0 | $197M | 5.7M | 34.84 | |
| Tesoro Corporation | 4.8 | $159M | 1.8M | 87.45 | |
| Advance Auto Parts (AAP) | 4.5 | $148M | 875k | 169.12 | |
| Vaneck Vectors Gold Miners mutual (GDX) | 4.0 | $133M | 6.4M | 20.92 | |
| Insulet Corporation (PODD) | 3.3 | $107M | 2.9M | 37.68 | |
| United States Steel Corporation (X) | 2.7 | $88M | 2.7M | 33.01 | |
| Alnylam Pharmaceuticals (ALNY) | 2.3 | $75M | 2.0M | 37.44 | |
| 1.9 | $62M | 3.8M | 16.30 | ||
| Skechers USA (SKX) | 1.4 | $46M | 1.9M | 24.58 | |
| Atara Biotherapeutics | 0.2 | $6.7M | 475k | 14.20 |
